Proteomics Global Market - Forecast to 2026
Proteomics is practically intricate as it includes the analysis and categorization including expression, structure, function, interaction, modification of overall protein signatures of a genome. Proteomics is gaining popularity as they are rendered crucial for early disease diagnosis, prognosis and monitor disease progression; personalized medicine along with playing a vital role in discovery and development of target molecules.
As estimated by IQ4I Research, the proteomics global market is expected to reach $27,670.3 million by 2026 growing at double digit CAGR from 2019 to 2026 due to increasing instance of chronic diseases, outbreak of new infectious diseases, technological innovations, increased need of personalized medicine, biomarker discovery and crop improvement research. The proteomics market is further segmented into product, application, end-user and geography.
By products, proteomics is segmented into instruments, consumables, software & services and proteomics services. Among products, the consumable accounted for the largest revenue; Consumables are further sub-segmented into Chromatography consumables, Electrophoresis consumables, Spectrometry consumables, Blotting consumables, Protein microarray consumables, X-Ray crystallography consumables and other consumables. Among consumables, spectrometry consumables sub-segment accounted for the largest revenue of due to increased use in protein identification & characterization, followed by chromatography and electrophoresis consumables which is attributed to the increasing research and advancements in the field of proteomics.
Proteomics instruments market is segmented based on product type into Chromatography, Spectroscopy, Electrophoresis, Blotting, Protein microarrays, Flow cytometry, X-ray crystallography, Surface Plasmon resonance and others. Among the instruments, spectrometry instrument accounted for the largest revenue, protein microarray segment is expected to grow with double digit CAGR from 2019 to 2026.
Software and services market is estimated to be XX million in 2019 and is expected grow at double digit CAGR from 2019 to 2026. Proteomics service market is segmented into sample preparation and purification, characterization and quantification. Among the proteomics service market characterization segment accounted for the largest revenue in 2019 and is expected to grow at a strong mid teen CAGR from 2019 to 2026. The factors driving the market are raising use of proteomics in drug discovery, development and manufacturing, increasing demand for personalized medicine, early disease detection, diagnosis and treatment, technological advancements favoring adoption of proteomics, growing availability of funds for research, whereas, factors such as high cost of instruments and special research materials such as antibodies, tags etc., reproducibility of result, lack of standardized workflow, problems in maintaining consistency, complexity, lack of skilled professionals & data management options, ethical concern and regulatory issues are restraining the market growth.
By Application, the proteomics global market is segmented into protein biomarker discovery, drug discovery, development & manufacturing, diagnostics, plant proteomics and others. Among Applications, drug discovery, development & manufacturing accounted for the largest revenue in 2019 and is expected grow at double digit CAGR from 2019 to 2026 due to increasing interest in biomarker discovery and biologic drugs, increasing need of early diagnosis, advancements in proteomic technologies. Protein biomarker discovery application is expected to grow with the mid teen CAGR from 2019 to 2026. The growth is attributed to the increased fund release for discovery of protein biomarkers for various difficult to cure diseases such as cancer and neurodegenerative diseases.
By End-user, the proteomics global market is segmented into pharma & biotech, CROs, diagnostic companies and academic & research institutions. Among End-users, Pharma & Biotech accounted for the largest revenue in 2019 & CROs segment is expected to grow with a strong early teen CAGR from 2019 to 2026. This is attributed to the increased outsourcing activities in the developing regions in order to reduce the investment and increase productivity.
By Geography, the proteomics global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, South Korea and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & others). Among this, North America region accounted for the largest revenue in 2019 and is expected to grow at early double digit CAGR from 2019 to 2026 due to high technological advancements, increased growing awareness towards importance of protein research, increased biologics drug pipeline, investments and funds, increased onset of chronic diseases, outburst of new infectious diseases in diseases, increased interest towards personalized medicine/precision medicine in North America are boosting the market of proteomics.
The Asia-Pacific is the fastest growing region in 2019 and is expected to grow at early teen CAGR from 2019 to 2026 due to rising incidences of chronic diseases like cancer, cardio vascular disease, CNS etc. emergence and recurrent outbreaks of new infectious disease making Asia-Pacific region hot spot, government initiatives to increase awareness about proteomic technologies, increasing high acceptance of technological advancements, increased CROs offering proteomics services, are driving the proteomics market in this region. The proteomics global market is consolidated and all the existing players in this market are involved in developing new and advanced technologies to maintain their market shares and emerging companies are coming up with novel techniques and products for their growth.
Some of the major players in Proteomics market include Thermo Fisher Scientific (U.S.), Danaher Corporation. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Perkin Elmer, Inc. (U.S.), Bruker Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.S.), Waters Corporation (U.S.) Abcam (U.K.), Agilent Technologies (U.S.) and PerkinElmer (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
As estimated by IQ4I Research, the proteomics global market is expected to reach $27,670.3 million by 2026 growing at double digit CAGR from 2019 to 2026 due to increasing instance of chronic diseases, outbreak of new infectious diseases, technological innovations, increased need of personalized medicine, biomarker discovery and crop improvement research. The proteomics market is further segmented into product, application, end-user and geography.
By products, proteomics is segmented into instruments, consumables, software & services and proteomics services. Among products, the consumable accounted for the largest revenue; Consumables are further sub-segmented into Chromatography consumables, Electrophoresis consumables, Spectrometry consumables, Blotting consumables, Protein microarray consumables, X-Ray crystallography consumables and other consumables. Among consumables, spectrometry consumables sub-segment accounted for the largest revenue of due to increased use in protein identification & characterization, followed by chromatography and electrophoresis consumables which is attributed to the increasing research and advancements in the field of proteomics.
Proteomics instruments market is segmented based on product type into Chromatography, Spectroscopy, Electrophoresis, Blotting, Protein microarrays, Flow cytometry, X-ray crystallography, Surface Plasmon resonance and others. Among the instruments, spectrometry instrument accounted for the largest revenue, protein microarray segment is expected to grow with double digit CAGR from 2019 to 2026.
Software and services market is estimated to be XX million in 2019 and is expected grow at double digit CAGR from 2019 to 2026. Proteomics service market is segmented into sample preparation and purification, characterization and quantification. Among the proteomics service market characterization segment accounted for the largest revenue in 2019 and is expected to grow at a strong mid teen CAGR from 2019 to 2026. The factors driving the market are raising use of proteomics in drug discovery, development and manufacturing, increasing demand for personalized medicine, early disease detection, diagnosis and treatment, technological advancements favoring adoption of proteomics, growing availability of funds for research, whereas, factors such as high cost of instruments and special research materials such as antibodies, tags etc., reproducibility of result, lack of standardized workflow, problems in maintaining consistency, complexity, lack of skilled professionals & data management options, ethical concern and regulatory issues are restraining the market growth.
By Application, the proteomics global market is segmented into protein biomarker discovery, drug discovery, development & manufacturing, diagnostics, plant proteomics and others. Among Applications, drug discovery, development & manufacturing accounted for the largest revenue in 2019 and is expected grow at double digit CAGR from 2019 to 2026 due to increasing interest in biomarker discovery and biologic drugs, increasing need of early diagnosis, advancements in proteomic technologies. Protein biomarker discovery application is expected to grow with the mid teen CAGR from 2019 to 2026. The growth is attributed to the increased fund release for discovery of protein biomarkers for various difficult to cure diseases such as cancer and neurodegenerative diseases.
By End-user, the proteomics global market is segmented into pharma & biotech, CROs, diagnostic companies and academic & research institutions. Among End-users, Pharma & Biotech accounted for the largest revenue in 2019 & CROs segment is expected to grow with a strong early teen CAGR from 2019 to 2026. This is attributed to the increased outsourcing activities in the developing regions in order to reduce the investment and increase productivity.
By Geography, the proteomics global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, South Korea and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & others). Among this, North America region accounted for the largest revenue in 2019 and is expected to grow at early double digit CAGR from 2019 to 2026 due to high technological advancements, increased growing awareness towards importance of protein research, increased biologics drug pipeline, investments and funds, increased onset of chronic diseases, outburst of new infectious diseases in diseases, increased interest towards personalized medicine/precision medicine in North America are boosting the market of proteomics.
The Asia-Pacific is the fastest growing region in 2019 and is expected to grow at early teen CAGR from 2019 to 2026 due to rising incidences of chronic diseases like cancer, cardio vascular disease, CNS etc. emergence and recurrent outbreaks of new infectious disease making Asia-Pacific region hot spot, government initiatives to increase awareness about proteomic technologies, increasing high acceptance of technological advancements, increased CROs offering proteomics services, are driving the proteomics market in this region. The proteomics global market is consolidated and all the existing players in this market are involved in developing new and advanced technologies to maintain their market shares and emerging companies are coming up with novel techniques and products for their growth.
Some of the major players in Proteomics market include Thermo Fisher Scientific (U.S.), Danaher Corporation. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Perkin Elmer, Inc. (U.S.), Bruker Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.S.), Waters Corporation (U.S.) Abcam (U.K.), Agilent Technologies (U.S.) and PerkinElmer (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Rest of North America
- Europe
- Germany
- France
- U.K.
- Rest of Europe
- Asia-Pacific
- Japan
- China
- South Korea
- Rest of APAC
- Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East and Others
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
2.7 PROTEOMICS APPROACHES
2.7.1 INTRODUCTION
2.7.1.1 BOTTOM UP APPROACH (SHOTGUN PROTEOMICS)
2.7.1.2 TOP DOWN APPROACH
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Rising use of proteomics in drug discovery, development and manufacturing
3.3.1.2 Increasing demand for personalized medicine
3.3.1.3 Early disease detection, diagnosis and treatment
3.3.1.4 Technological advancements favoring adoption of proteomics
3.3.1.5 Growing availability of funds for research
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of instruments and special research materials
3.3.2.2 Maintaining consistency, reproducibility of result, lack of standardization, complexity
3.3.2.3 Lack of skilled professionals and data management options
3.3.2.4 Data security and regulatory issues
3.4 SELECTED PRODUCTS AND SERVICE PRICE LIST
3.5 REGULATORY AFFAIRS
3.5.1 NORTH AMERICA
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 JAPAN
3.5.5 SOUTH KOREA
3.5.6 BRAZIL
3.6 TECHNOLOGICAL ADVANCEMENTS
3.6.1 INTRODUCTION
3.6.2 ADVACEMENTS IN 4D PROTEOMICS
3.6.3 ADVANCEMENTS IN CRYO ELECTRON MICROSCOPES
3.6.4 ADVANCEMENTS IN CAPILLARY ELECTROPHORESIS
3.6.5 ADVANCEMENTS IN LABEL FREE QUANTIFICATION
3.6.6 ADVANCEMENTS IN MACHINE LEARNING
3.7 PORTER’S FIVE FORCE ANALYSIS
3.7.1 THREAT OF NEW ENTRANTS
3.7.2 THREAT OF SUBSTITUTES
3.7.3 RIVALRY AMONG EXISTING COMPETITORS
3.7.4 BARGAINING POWER OF SUPPLIERS
3.7.5 BARGAINING POWER OF BUYERS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8.1 PROTEOMICS GLOBAL MARKET SHARE ANALYSIS
4 PROTEOMICS GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INSTRUMENTS
4.2.1 SPECTROMETRY
4.2.2 CHROMATOGRAPHY
4.2.3 PROTEIN MICROARRAYS
4.2.4 ELECTROPHORESIS
4.2.5 X-RAY CRYSTALLOGRAPHY
4.2.6 BLOTTING
4.2.7 SURFACE PLASMON RESONANCE(SPR)
4.2.8 FLOW CYTOMETRY
4.2.9 OTHERS
4.3 CONSUMABLES
4.3.1 SPECTROMETRY CONSUMABLES
4.3.2 CHROMATOGRAPHY CONSUMABLES
4.3.3 ELECTROPHORESIS CONSUMABLES
4.3.4 X-RAY CRYSTALLOGRAPHY CONSUMABLES
4.3.5 BLOTTING CONSUMABLES
4.3.6 PROTEIN MICROARRAY CONSUMABLES
4.3.7 OTHER CONSUMABLES
4.4 SOFTWARE AND SERVICES
4.5 PROTEOMIC SERVICES
4.5.1 PROCESS TYPE
4.5.1.1 Sample preparation and purification
4.5.1.2 Protein characterization
4.5.1.3 Protein quantification
5 PROTEOMICS GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 PROTEIN BIOMARKER DISCOVERY
5.3 DISCOVERY, DEVELOPMENT AND MANUFACTURING
5.4 DIAGNOSTICS
5.5 PLANT PROTEOMICS
5.6 OTHERS
6 PROTEOMICS GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 PHARMA BIOTECH
6.3 CONTRACT RESEARCH ORGANIZATIONS
6.4 ACADEMIC AND RESEARCH INSTITUTES
6.5 DIAGNOSTIC COMPANIES
7 PROTEOMICS GLOBAL MARKET, BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K
7.3.3 FRANCE
7.3.4 REST OF EUROPE
7.4 ASIA-PACIFIC
7.4.1 CHINA
7.4.2 JAPAN
7.4.3 SOUTH KOREA
7.4.4 REST OF APAC
7.5 REST OF THE WORLD
7.6 BRAZIL
7.7 REST OF LATIN AMERICA
7.8 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCH
8.3 AGREEMENTS, PARTERNERSHIPS AND COLLABORATIONS
8.4 APPROVAL
8.5 ACQUISITION
8.6 OTHERS
9 COMPANY PROFILES
9.1 ABCAM PLC.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 AGILENT TECHNOLOGIES
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 BECTON, DICKINSON AND COMPANY
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BIO-RAD LABORATORIES
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 RODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 BRUKER CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 DANAHER CORPORATION
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 GENERAL ELECTRICAL COMPANY
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 MERCK KGAA
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 PERKINELMER, INC.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 THERMO FISHER SCIENTIFIC INC.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 WATERS CORPORATION
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
2.7 PROTEOMICS APPROACHES
2.7.1 INTRODUCTION
2.7.1.1 BOTTOM UP APPROACH (SHOTGUN PROTEOMICS)
2.7.1.2 TOP DOWN APPROACH
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Rising use of proteomics in drug discovery, development and manufacturing
3.3.1.2 Increasing demand for personalized medicine
3.3.1.3 Early disease detection, diagnosis and treatment
3.3.1.4 Technological advancements favoring adoption of proteomics
3.3.1.5 Growing availability of funds for research
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of instruments and special research materials
3.3.2.2 Maintaining consistency, reproducibility of result, lack of standardization, complexity
3.3.2.3 Lack of skilled professionals and data management options
3.3.2.4 Data security and regulatory issues
3.4 SELECTED PRODUCTS AND SERVICE PRICE LIST
3.5 REGULATORY AFFAIRS
3.5.1 NORTH AMERICA
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 JAPAN
3.5.5 SOUTH KOREA
3.5.6 BRAZIL
3.6 TECHNOLOGICAL ADVANCEMENTS
3.6.1 INTRODUCTION
3.6.2 ADVACEMENTS IN 4D PROTEOMICS
3.6.3 ADVANCEMENTS IN CRYO ELECTRON MICROSCOPES
3.6.4 ADVANCEMENTS IN CAPILLARY ELECTROPHORESIS
3.6.5 ADVANCEMENTS IN LABEL FREE QUANTIFICATION
3.6.6 ADVANCEMENTS IN MACHINE LEARNING
3.7 PORTER’S FIVE FORCE ANALYSIS
3.7.1 THREAT OF NEW ENTRANTS
3.7.2 THREAT OF SUBSTITUTES
3.7.3 RIVALRY AMONG EXISTING COMPETITORS
3.7.4 BARGAINING POWER OF SUPPLIERS
3.7.5 BARGAINING POWER OF BUYERS
3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8.1 PROTEOMICS GLOBAL MARKET SHARE ANALYSIS
4 PROTEOMICS GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 INSTRUMENTS
4.2.1 SPECTROMETRY
4.2.2 CHROMATOGRAPHY
4.2.3 PROTEIN MICROARRAYS
4.2.4 ELECTROPHORESIS
4.2.5 X-RAY CRYSTALLOGRAPHY
4.2.6 BLOTTING
4.2.7 SURFACE PLASMON RESONANCE(SPR)
4.2.8 FLOW CYTOMETRY
4.2.9 OTHERS
4.3 CONSUMABLES
4.3.1 SPECTROMETRY CONSUMABLES
4.3.2 CHROMATOGRAPHY CONSUMABLES
4.3.3 ELECTROPHORESIS CONSUMABLES
4.3.4 X-RAY CRYSTALLOGRAPHY CONSUMABLES
4.3.5 BLOTTING CONSUMABLES
4.3.6 PROTEIN MICROARRAY CONSUMABLES
4.3.7 OTHER CONSUMABLES
4.4 SOFTWARE AND SERVICES
4.5 PROTEOMIC SERVICES
4.5.1 PROCESS TYPE
4.5.1.1 Sample preparation and purification
4.5.1.2 Protein characterization
4.5.1.3 Protein quantification
5 PROTEOMICS GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 PROTEIN BIOMARKER DISCOVERY
5.3 DISCOVERY, DEVELOPMENT AND MANUFACTURING
5.4 DIAGNOSTICS
5.5 PLANT PROTEOMICS
5.6 OTHERS
6 PROTEOMICS GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 PHARMA BIOTECH
6.3 CONTRACT RESEARCH ORGANIZATIONS
6.4 ACADEMIC AND RESEARCH INSTITUTES
6.5 DIAGNOSTIC COMPANIES
7 PROTEOMICS GLOBAL MARKET, BY REGION
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 REST OF NORTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K
7.3.3 FRANCE
7.3.4 REST OF EUROPE
7.4 ASIA-PACIFIC
7.4.1 CHINA
7.4.2 JAPAN
7.4.3 SOUTH KOREA
7.4.4 REST OF APAC
7.5 REST OF THE WORLD
7.6 BRAZIL
7.7 REST OF LATIN AMERICA
7.8 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 NEW PRODUCT LAUNCH
8.3 AGREEMENTS, PARTERNERSHIPS AND COLLABORATIONS
8.4 APPROVAL
8.5 ACQUISITION
8.6 OTHERS
9 COMPANY PROFILES
9.1 ABCAM PLC.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 AGILENT TECHNOLOGIES
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 BECTON, DICKINSON AND COMPANY
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BIO-RAD LABORATORIES
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 RODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 BRUKER CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 DANAHER CORPORATION
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 GENERAL ELECTRICAL COMPANY
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 MERCK KGAA
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 PERKINELMER, INC.
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 THERMO FISHER SCIENTIFIC INC.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 WATERS CORPORATION
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 PROTEOMICS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 3 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 4 INSTRUMENTS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 5 INSTRUMENTS GLOBAL MARKET REVENUE, BY REGIONS, (2018-2026) ($MN)
TABLE 6 SPECTROMETRY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 7 CHROMATOGRAPY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 8 PROTEIN MICROARRAY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 9 ELECTROPHOREIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 10 X-RAY CRYSTALLOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 11 BLOTTING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 12 SURFACE PLASMON RESONANCE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 13 FLOW CYTOMETRY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 14 OTHER INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 15 CONSUMABLES GLOBAL MARKET REVENUE, BY INSTRUMENT TYPE, (2018-2026) ($MN)
TABLE 16 CONSUMABLES GLOBAL MARKET REVENUE, BY REGIONS, (2018-2026) ($MN)
TABLE 17 SPECTROMETRY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 18 CHROMATOGRAPHY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 19 ELECTROPHORESIS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 20 X-RAY CRYSTALLOGRAPHY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 21 BLOTTING CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 22 PROTEIN MICROARRAY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 23 OTHER CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 24 SOFTWARE AND SERVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 25 PROTEOMIC SERVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 26 PROTEOMIC SERVICES GLOBAL MARKET REVENUE, BY PROCESS TYPE, (2018-2026) ($MN)
TABLE 27 SAMPLE PREPARATION AND PURIFICATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 28 CHARACTERIZATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 29 QUANTIFICATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 30 PROTEOMICS GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 31 PROTEIN BIOMARKER DISCOVERY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 32 DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 33 DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 34 PLANT PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 35 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 36 PROTEOMICS GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
TABLE 37 PHARMA BIOTECH GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 38 CONTRACT RESEARCH ORGANIZATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 39 ACADEMIC & RESEARCH INSTITUTES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 40 DIAGNOSTIC COMPANIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 41 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 42 NORTH AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 43 NORTH AMERICA CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
TABLE 44 NORTH AMERICA INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
TABLE 45 NORTH AMERICA PROTEOMICS MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
TABLE 46 NORTH AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 47 NORTH AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 48 EUROPE PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 49 EUROPE CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE, (2018-2026) ($MN)
TABLE 50 EUROPE INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 51 EUROPE PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE, (2018-2026) ($MN)
TABLE 52 EUROPE PROTEOMICS MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 53 EUROPE PROTEOMICS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 54 EUROPE PROTEOMICS MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 55 ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 56 ASIA-PACIFIC CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
TABLE 57 ASIA-PACIFIC INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
TABLE 58 ASIA-PACIFIC PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
TABLE 59 ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 60 ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 61 ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 62 ROW PROTEOMICS MARKET REVENUE, BY PRODUCT (2018-2026) ($MN)
TABLE 63 ROW CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
TABLE 64 ROW INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
TABLE 65 ROW PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
TABLE 66 ROW PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 67 ROW PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 68 ROW PROTEOMICS MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 69 NEW PRODUCT LAUNCH (2018-2019)
TABLE 70 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS (2018-2019)
TABLE 71 APPROVALS (2018-2019)
TABLE 72 ACQUSITION(2018-2019)
TABLE 73 OTHERS (2018-2019)
TABLE 74 ABCAM : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 75 ABCAM: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 76 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q3)) ($MN)
TABLE 77 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q3)) ($MN)
TABLE 78 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY REGION, (2017-2019(Q3)) ($MN)
TABLE 79 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q3)) ($MN)
TABLE 80 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q3)) ($MN)
TABLE 81 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, LIFE SCIENCE SEGMENT, (2017-2019(Q3)) ($MN)
TABLE 82 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY REGION, (2017-2019(Q3)) ($MN)
TABLE 83 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q2)) ($MN)
TABLE 84 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q2)) ($MN)
TABLE 85 BIO-RAD LABORATORIES: TOTAL REVENUE, BY REGION, (2017-2019(Q2)) ($MN)
TABLE 86 BRUKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 87 BRUKER COPERATION: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 88 BRUKER CORPORATION: TOTAL REVENUE, BY SUB-SEGMENT, (2017-2019) ($MN)
TABLE 89 BRUKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 90 DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q2)) ($MN)
TABLE 91 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q2)) ($MN)
TABLE 92 DANAHER CORPORATION: TOTAL REVENUE, BY REGION, (2017-2019(Q2)) ($MN)
TABLE 93 GENERAL ELECTRONIC COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 94 GENERAL ELECTRONIC COMPANY: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 95 GENERAL ELECTRONIC COMPANY: HEALTHCARE BY SUB-SEGMENT, (2017-2019) ($MN)
TABLE 96 GENERAL ELECTRONIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 97 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 98 MERCK KGAA: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 99 MERCK KGAA COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 100 PERKINELMER,INC. : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 101 PERKINELMER,INC.: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 102 PERKINELMER,INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 103 THERMO FISHER SCIENTIFIC INC. : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 104 THERMO FISHER SCIENTIFIC INC.: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 105 THERMO FISHER SCIENTIFIC INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 106 WATERS CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 107 WATERS CORPORATION: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 108 WATERS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 1 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 PROTEOMICS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 3 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 4 INSTRUMENTS GLOBAL MARKET REVENUE, BY PRODUCTS, (2018-2026) ($MN)
TABLE 5 INSTRUMENTS GLOBAL MARKET REVENUE, BY REGIONS, (2018-2026) ($MN)
TABLE 6 SPECTROMETRY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 7 CHROMATOGRAPY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 8 PROTEIN MICROARRAY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 9 ELECTROPHOREIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 10 X-RAY CRYSTALLOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 11 BLOTTING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 12 SURFACE PLASMON RESONANCE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 13 FLOW CYTOMETRY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 14 OTHER INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 15 CONSUMABLES GLOBAL MARKET REVENUE, BY INSTRUMENT TYPE, (2018-2026) ($MN)
TABLE 16 CONSUMABLES GLOBAL MARKET REVENUE, BY REGIONS, (2018-2026) ($MN)
TABLE 17 SPECTROMETRY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 18 CHROMATOGRAPHY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 19 ELECTROPHORESIS CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 20 X-RAY CRYSTALLOGRAPHY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 21 BLOTTING CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 22 PROTEIN MICROARRAY CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 23 OTHER CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 24 SOFTWARE AND SERVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 25 PROTEOMIC SERVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 26 PROTEOMIC SERVICES GLOBAL MARKET REVENUE, BY PROCESS TYPE, (2018-2026) ($MN)
TABLE 27 SAMPLE PREPARATION AND PURIFICATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 28 CHARACTERIZATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 29 QUANTIFICATION GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 30 PROTEOMICS GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 31 PROTEIN BIOMARKER DISCOVERY GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 32 DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 33 DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 34 PLANT PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 35 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 36 PROTEOMICS GLOBAL MARKET REVENUE, BY END-USERS, (2018-2026) ($MN)
TABLE 37 PHARMA BIOTECH GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 38 CONTRACT RESEARCH ORGANIZATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 39 ACADEMIC & RESEARCH INSTITUTES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 40 DIAGNOSTIC COMPANIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 41 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 42 NORTH AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 43 NORTH AMERICA CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
TABLE 44 NORTH AMERICA INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
TABLE 45 NORTH AMERICA PROTEOMICS MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
TABLE 46 NORTH AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 47 NORTH AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 48 EUROPE PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 49 EUROPE CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE, (2018-2026) ($MN)
TABLE 50 EUROPE INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 51 EUROPE PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE, (2018-2026) ($MN)
TABLE 52 EUROPE PROTEOMICS MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 53 EUROPE PROTEOMICS MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 54 EUROPE PROTEOMICS MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 55 ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 56 ASIA-PACIFIC CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
TABLE 57 ASIA-PACIFIC INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
TABLE 58 ASIA-PACIFIC PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
TABLE 59 ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 60 ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 61 ASIA-PACIFIC PROTEOMICS MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 62 ROW PROTEOMICS MARKET REVENUE, BY PRODUCT (2018-2026) ($MN)
TABLE 63 ROW CONSUMABLES MARKET REVENUE, BY INSTRUMENT TYPE (2018-2026) ($MN)
TABLE 64 ROW INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018-2026) ($MN)
TABLE 65 ROW PROTEOMICS SERVICE MARKET REVENUE, BY SERVICE TYPE (2018-2026) ($MN)
TABLE 66 ROW PROTEOMICS MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
TABLE 67 ROW PROTEOMICS MARKET REVENUE, BY END-USER (2018-2026) ($MN)
TABLE 68 ROW PROTEOMICS MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
TABLE 69 NEW PRODUCT LAUNCH (2018-2019)
TABLE 70 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS (2018-2019)
TABLE 71 APPROVALS (2018-2019)
TABLE 72 ACQUSITION(2018-2019)
TABLE 73 OTHERS (2018-2019)
TABLE 74 ABCAM : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 75 ABCAM: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 76 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q3)) ($MN)
TABLE 77 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q3)) ($MN)
TABLE 78 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY REGION, (2017-2019(Q3)) ($MN)
TABLE 79 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q3)) ($MN)
TABLE 80 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q3)) ($MN)
TABLE 81 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, LIFE SCIENCE SEGMENT, (2017-2019(Q3)) ($MN)
TABLE 82 BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY REGION, (2017-2019(Q3)) ($MN)
TABLE 83 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q2)) ($MN)
TABLE 84 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q2)) ($MN)
TABLE 85 BIO-RAD LABORATORIES: TOTAL REVENUE, BY REGION, (2017-2019(Q2)) ($MN)
TABLE 86 BRUKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 87 BRUKER COPERATION: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 88 BRUKER CORPORATION: TOTAL REVENUE, BY SUB-SEGMENT, (2017-2019) ($MN)
TABLE 89 BRUKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 90 DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019(Q2)) ($MN)
TABLE 91 DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENT, (2017-2019(Q2)) ($MN)
TABLE 92 DANAHER CORPORATION: TOTAL REVENUE, BY REGION, (2017-2019(Q2)) ($MN)
TABLE 93 GENERAL ELECTRONIC COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 94 GENERAL ELECTRONIC COMPANY: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 95 GENERAL ELECTRONIC COMPANY: HEALTHCARE BY SUB-SEGMENT, (2017-2019) ($MN)
TABLE 96 GENERAL ELECTRONIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 97 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 98 MERCK KGAA: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 99 MERCK KGAA COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 100 PERKINELMER,INC. : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 101 PERKINELMER,INC.: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 102 PERKINELMER,INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 103 THERMO FISHER SCIENTIFIC INC. : TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 104 THERMO FISHER SCIENTIFIC INC.: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 105 THERMO FISHER SCIENTIFIC INC.: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 106 WATERS CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 107 WATERS CORPORATION: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 108 WATERS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
LIST OF FIGURES
FIGURE 1 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: PROTEOMICS GLOBAL MARKET
FIGURE 3 PROTEOMICS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 PROTEOMICS GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 PROTEOMICS GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 PROTEOMICS APPROACH
FIGURE 7 PROTEOMICS GLOBAL MARKET: MARKET SEGMENTATION
FIGURE 8 PROCESS IN PROTEOMICS
FIGURE 9 PROCESS AND APPLICATIONS OF PROTEOMICS
FIGURE 10 PROTEOMICS GLOBAL MARKET: PORTER’S FIVE FORCE ANALYSIS
FIGURE 11 PROTEOMICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
FIGURE 12 PROTEOMOICS GLOBAL MARKET SHARE, BY PRODUCTS (2019 V’S 2026) (%)
FIGURE 13 INSTRUMENTS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 14 INSTRUMENTS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 15 SPECTROMETRY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 16 CHROMATOGRAPHY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 17 PROTEIN MICROARRAY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 18 ELECTROPHORESIS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 19 X-RAY CRYSTALLOGRAPHY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 20 BLOTTING GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 21 SURFACE PLASMON RESONANCE GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 22 FLOWCYTOMETRY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 23 OTHERS INSTRUMENT GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 24 CONSUMABLES GLOBAL MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 25 CONSUMABLES MARKET SHARE BY REGION (2019 V’S 2026) (%)
FIGURE 26 SPECTROMETRY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 27 CHROMATOGRAPHY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 28 ELECTROPHORESIS CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 29 X-RAY CRYSTALLOGRAPHY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 30 BLOTTING CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 31 PROTEIN MICROARRAY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 32 OTHERS CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 33 SOFTWARE AND SERVICES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 34 PROTEOMIC SERVICES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 35 PROTEOMICS SERVICES GLOBAL MARKET SHARE, BY PROCESS TYPE (2019 V’S 2026) (%)
FIGURE 36 SAMPLE PREPARATION AND PURIFICATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 37 CHARACTERIZATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 38 QUANTIFICATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 39 PROTEOMICS GLOBAL MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 40 PROTEIN BIOMARKER DISCOVERY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 41 DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 42 DIAGNOSTICS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 43 PLANT PROTEOMICS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 44 OTHERS APPLICATIONS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 45 PROTEOMICS GLOBAL MARKET SHARE, BY END-USERS (2019 V’S 2026) (%)
FIGURE 46 PHARMA BIOTECH GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 47 CONTRACT RESEARCH ORGANIZATIONS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 48 ACADEMIC & RESEARCH INSTITUTES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 49 DIAGNOSTICS COMPANIES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 50 PROTEOMICS GLOBAL MARKET REVENUE, BY GEOGRAPHY (2018 - 2026) ($MN), CAGR (%)
FIGURE 51 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION (2019) ($MN)
FIGURE 52 NORTH AMERICA PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
FIGURE 53 NORTH AMERICA CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 54 NORTH AMERICA INSTRUMENT MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 55 NORTH AMERICA PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
FIGURE 56 NORTH AMERICA PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 57 NORTH AMERICA PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
FIGURE 58 U.S. PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 59 U.S. PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 60 U.S. PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 61 U.S. PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 62 REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 63 REST OF NORTH AMERICA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 64 REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 65 REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 66 EUROPE PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
FIGURE 67 EUROPE CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 68 EUROPE INSTRUMNET MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 69 EUROPE PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
FIGURE 70 EUROPE PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 71 EUROPE PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
FIGURE 72 EUROPE PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
FIGURE 73 GERMANY PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 74 GERMANY PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 75 GERMANY PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 76 GERMANY PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN) 256_Toc33720035
FIGURE 77 U.K PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 78 U.K PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 79 U.K. PROTEOMICS MARKET REVENUE, BY APPLICATION TYPE (2019 V’S 2026) ($MN)
FIGURE 80 U.K.PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 81 FRANCE PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 82 FRANCE PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 83 FRANCE PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 84 FRANCE PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 85 REST OF EUROPE PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 86 REST OF EUROPE PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 87 REST OF EUROPE PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 88 REST OF EUROPE PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 89 ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
FIGURE 90 ASIA-PACIFIC CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 91 ASIA-PACIFIC INSTRUMENT MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 92 ASIA-PACIFIC PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
FIGURE 93 ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 94 ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
FIGURE 95 ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
FIGURE 96 CHINA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 97 CHINA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 98 CHINA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 99 CHINA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 100 JAPAN PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 101 JAPAN PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 102 JAPAN PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 103 JAPAN PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 104 SOUTH KOREA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 105 SOUTH KOREA INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 106 SOUTH KOREA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 107 SOUTH KOREA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 108 REST OF APAC PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 109 REST OF APAC PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 110 REST OF APAC PROTEOMICS MARKET REVENUE, BY APPLICATION TYPE (2019 V’S 2026) ($MN)
FIGURE 111 REST OF APAC PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 112 REST OF THE WORLD PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 113 REST OF THE WORLD CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 114 REST OF THE WORLD INSTRUMNET MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 115 REST OF THE WORLD PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
FIGURE 116 REST OF THE WORLD PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 117 REST OF THE WORLD PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
FIGURE 118 REST OF THE WORLD PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
FIGURE 119 BRAZIL PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 120 BRAZIL PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 121 BRAZIL PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 122 BRAZIL PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 123 REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 124 REST OF LATIN AMERICA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 125 REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 126 REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 127 MIDDLE EAST AND OTHERS PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 128 MIDDLE EAST AND OTHERS PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 129 MIDDLE EAST AND OTHERS PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 130 REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 131 KEY GROWTH STRATEGIES (2018-2019)
FIGURE 132 OVERVIEW: ABCAM PLC
FIGURE 133 SWOT: ABCAM PLC.
FIGURE 134 OVERVIEW: AGILENT TECHNOLOGIES
FIGURE 135 SWOT: AGILENT TECHNOLOGIES
FIGURE 136 OVERVIEW: BECTON, DICKINSON AND COMPANY
FIGURE 137 SWOT: BECTON, DICKINSON AND COMPANY
FIGURE 138 OVERVIEW: BIO-RAD LABORATORIES
FIGURE 139 SWOT: BIO-RAD LABORATORIES
FIGURE 140 OVERVIEW: BRUKER CORPORATION
FIGURE 141 SWOT: BRUKER CO-OPERATION
FIGURE 142 OVERVIEW: DANAHER CORPORATION
FIGURE 143 SWOT: DANAHER CORPORATION
FIGURE 144 OVERVIEW: GENERAL ELECTRICAL COMPANY
FIGURE 145 SWOT: GENERAL ELECTRONIC COMPANY
FIGURE 146 OVERVIEW: MERCK KGAA
FIGURE 147 SWOT: MERCK KGAA CORPORATION
FIGURE 148 OVERVIEW: PERKIN ELMER, INC.
FIGURE 149 SWOT: PERKIN ELMER, INC.
FIGURE 150 OVERVIEW: THERMO FISHER SCIENTIFIC INC.
FIGURE 151 SWOT: THERMO FISHER SCIENTIFIC
FIGURE 152 OVERVIEW: WATERS CORPORATION
FIGURE 153 SWOT: WATERS CORPORATION
FIGURE 1 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: PROTEOMICS GLOBAL MARKET
FIGURE 3 PROTEOMICS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 PROTEOMICS GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 PROTEOMICS GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 PROTEOMICS APPROACH
FIGURE 7 PROTEOMICS GLOBAL MARKET: MARKET SEGMENTATION
FIGURE 8 PROCESS IN PROTEOMICS
FIGURE 9 PROCESS AND APPLICATIONS OF PROTEOMICS
FIGURE 10 PROTEOMICS GLOBAL MARKET: PORTER’S FIVE FORCE ANALYSIS
FIGURE 11 PROTEOMICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
FIGURE 12 PROTEOMOICS GLOBAL MARKET SHARE, BY PRODUCTS (2019 V’S 2026) (%)
FIGURE 13 INSTRUMENTS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 14 INSTRUMENTS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 15 SPECTROMETRY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 16 CHROMATOGRAPHY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 17 PROTEIN MICROARRAY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 18 ELECTROPHORESIS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 19 X-RAY CRYSTALLOGRAPHY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 20 BLOTTING GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 21 SURFACE PLASMON RESONANCE GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 22 FLOWCYTOMETRY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 23 OTHERS INSTRUMENT GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 24 CONSUMABLES GLOBAL MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 25 CONSUMABLES MARKET SHARE BY REGION (2019 V’S 2026) (%)
FIGURE 26 SPECTROMETRY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 27 CHROMATOGRAPHY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 28 ELECTROPHORESIS CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 29 X-RAY CRYSTALLOGRAPHY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 30 BLOTTING CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 31 PROTEIN MICROARRAY CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 32 OTHERS CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 33 SOFTWARE AND SERVICES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 34 PROTEOMIC SERVICES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 35 PROTEOMICS SERVICES GLOBAL MARKET SHARE, BY PROCESS TYPE (2019 V’S 2026) (%)
FIGURE 36 SAMPLE PREPARATION AND PURIFICATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 37 CHARACTERIZATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 38 QUANTIFICATION GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 39 PROTEOMICS GLOBAL MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 40 PROTEIN BIOMARKER DISCOVERY GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 41 DISCOVERY, DEVELOPMENT AND MANUFACTURING GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 42 DIAGNOSTICS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 43 PLANT PROTEOMICS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 44 OTHERS APPLICATIONS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 45 PROTEOMICS GLOBAL MARKET SHARE, BY END-USERS (2019 V’S 2026) (%)
FIGURE 46 PHARMA BIOTECH GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 47 CONTRACT RESEARCH ORGANIZATIONS GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 48 ACADEMIC & RESEARCH INSTITUTES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 49 DIAGNOSTICS COMPANIES GLOBAL MARKET SHARE, BY REGION (2019 V’S 2026) (%)
FIGURE 50 PROTEOMICS GLOBAL MARKET REVENUE, BY GEOGRAPHY (2018 - 2026) ($MN), CAGR (%)
FIGURE 51 PROTEOMICS GLOBAL MARKET REVENUE, BY REGION (2019) ($MN)
FIGURE 52 NORTH AMERICA PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
FIGURE 53 NORTH AMERICA CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 54 NORTH AMERICA INSTRUMENT MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 55 NORTH AMERICA PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
FIGURE 56 NORTH AMERICA PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 57 NORTH AMERICA PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
FIGURE 58 U.S. PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 59 U.S. PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 60 U.S. PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 61 U.S. PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 62 REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 63 REST OF NORTH AMERICA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 64 REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 65 REST OF NORTH AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 66 EUROPE PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
FIGURE 67 EUROPE CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 68 EUROPE INSTRUMNET MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 69 EUROPE PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
FIGURE 70 EUROPE PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 71 EUROPE PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
FIGURE 72 EUROPE PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
FIGURE 73 GERMANY PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 74 GERMANY PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 75 GERMANY PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 76 GERMANY PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN) 256_Toc33720035
FIGURE 77 U.K PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 78 U.K PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 79 U.K. PROTEOMICS MARKET REVENUE, BY APPLICATION TYPE (2019 V’S 2026) ($MN)
FIGURE 80 U.K.PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 81 FRANCE PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 82 FRANCE PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 83 FRANCE PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 84 FRANCE PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 85 REST OF EUROPE PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 86 REST OF EUROPE PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 87 REST OF EUROPE PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 88 REST OF EUROPE PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 89 ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY PRODUCT (2019 V’S 2026) (%)
FIGURE 90 ASIA-PACIFIC CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 91 ASIA-PACIFIC INSTRUMENT MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 92 ASIA-PACIFIC PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
FIGURE 93 ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 94 ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
FIGURE 95 ASIA-PACIFIC PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
FIGURE 96 CHINA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 97 CHINA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 98 CHINA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 99 CHINA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 100 JAPAN PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 101 JAPAN PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 102 JAPAN PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 103 JAPAN PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 104 SOUTH KOREA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 105 SOUTH KOREA INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 106 SOUTH KOREA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 107 SOUTH KOREA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 108 REST OF APAC PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 109 REST OF APAC PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 110 REST OF APAC PROTEOMICS MARKET REVENUE, BY APPLICATION TYPE (2019 V’S 2026) ($MN)
FIGURE 111 REST OF APAC PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 112 REST OF THE WORLD PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 113 REST OF THE WORLD CONSUMABLES MARKET SHARE, BY INSTRUMENT TYPE (2019 V’S 2026) (%)
FIGURE 114 REST OF THE WORLD INSTRUMNET MARKET SHARE, BY PRODUCT TYPE (2019 V’S 2026) (%)
FIGURE 115 REST OF THE WORLD PROTEOMICS SERVICE MARKET SHARE, BY SERVICE TYPE (2019 V’S 2026) (%)
FIGURE 116 REST OF THE WORLD PROTEOMICS MARKET SHARE, BY APPLICATION (2019 V’S 2026) (%)
FIGURE 117 REST OF THE WORLD PROTEOMICS MARKET SHARE, BY END-USER (2019 V’S 2026) (%)
FIGURE 118 REST OF THE WORLD PROTEOMICS MARKET SHARE, BY COUNTRY (2019 V’S 2026) (%)
FIGURE 119 BRAZIL PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 120 BRAZIL PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 121 BRAZIL PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 122 BRAZIL PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 123 REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 124 REST OF LATIN AMERICA PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 125 REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 126 REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 127 MIDDLE EAST AND OTHERS PROTEOMICS MARKET REVENUE, BY PRODUCT (2019 V’S 2026) ($MN)
FIGURE 128 MIDDLE EAST AND OTHERS PROTEOMICS INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2019 V’S 2026) ($MN)
FIGURE 129 MIDDLE EAST AND OTHERS PROTEOMICS MARKET REVENUE, BY APPLICATION (2019 V’S 2026) ($MN)
FIGURE 130 REST OF LATIN AMERICA PROTEOMICS MARKET REVENUE, BY END-USER (2019 V’S 2026) ($MN)
FIGURE 131 KEY GROWTH STRATEGIES (2018-2019)
FIGURE 132 OVERVIEW: ABCAM PLC
FIGURE 133 SWOT: ABCAM PLC.
FIGURE 134 OVERVIEW: AGILENT TECHNOLOGIES
FIGURE 135 SWOT: AGILENT TECHNOLOGIES
FIGURE 136 OVERVIEW: BECTON, DICKINSON AND COMPANY
FIGURE 137 SWOT: BECTON, DICKINSON AND COMPANY
FIGURE 138 OVERVIEW: BIO-RAD LABORATORIES
FIGURE 139 SWOT: BIO-RAD LABORATORIES
FIGURE 140 OVERVIEW: BRUKER CORPORATION
FIGURE 141 SWOT: BRUKER CO-OPERATION
FIGURE 142 OVERVIEW: DANAHER CORPORATION
FIGURE 143 SWOT: DANAHER CORPORATION
FIGURE 144 OVERVIEW: GENERAL ELECTRICAL COMPANY
FIGURE 145 SWOT: GENERAL ELECTRONIC COMPANY
FIGURE 146 OVERVIEW: MERCK KGAA
FIGURE 147 SWOT: MERCK KGAA CORPORATION
FIGURE 148 OVERVIEW: PERKIN ELMER, INC.
FIGURE 149 SWOT: PERKIN ELMER, INC.
FIGURE 150 OVERVIEW: THERMO FISHER SCIENTIFIC INC.
FIGURE 151 SWOT: THERMO FISHER SCIENTIFIC
FIGURE 152 OVERVIEW: WATERS CORPORATION
FIGURE 153 SWOT: WATERS CORPORATION
